$XORTX Therapeutics Inc.(XRTX)$ There’s great news circulating about Xortx Therapeutics (NASDAQ:XRTX) today. In a clinical study, XORLO, Xortx’s orally administered brand of oxypurinol, demonstrated a “substantial increase” in bioavailability. This news caused a huge spike in XRTX stock this morning, though it has since lost some momentum.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论

暂无评论

